Found 8 matching trials
Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV PHASE2 This is a randomized, open-label trial, to assess whether a single dose of ...
Show More Location
Kambia Research Centre
Learn More & Join Trial
Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO Trial PHASE4 This phase IV trial compares 3 different dosing schedules to find the optim...
Show More Location
Evandro Chagas National Institute of Infectious Diseases (INI), Oswaldo Cruz Foundation (FIOCRUZ) STD and AIDS Clinical Research Laboratory
Learn More & Join Trial
Persistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students PHASE4 Since the 2019-2020 school year, the province of Quebec (Canada) has been a...
Show More Location
Centre de recherche du CHU de Québec-Université Laval
Learn More & Join Trial
Immunogenicity of HPV Vaccine in Transplant Recipients. PHASE4 To measure levels of HPV antibodies in post-solid-organ transplant recipien...
Show More Status
Active Not Recruiting
Location
Froedtert Lutheran Memorial Hospital
Learn More & Join Trial
A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV) PHASE4 This is a non-randomized, open label study to assess the reduction of Human...
Show More Location
Gynaecology Unit, Bellvitge University Hospital (HUB)
Learn More & Join Trial
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV PHASE4 There are very little data on human papillomavirus (HPV) vaccination among ...
Show More Location
Positive Health Services - Fraser Health
Learn More & Join Trial
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini PHASE4 This is a multi-site, open-label non-inferiority study of the 9vHPV vaccine...
Show More Learn More & Join Trial
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen PHASE4 The goal of this study is to explore and evaluate whether a 2-dose schedule...
Show More Status
Active Not Recruiting
Location
Boston Medical Center
Learn More & Join Trial